Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Observational Registry of the Treatment of Glanzmann's Thrombasthenia

This study has been completed.
Information provided by (Responsible Party):
Novo Nordisk A/S Identifier:
First received: October 7, 2011
Last updated: December 19, 2014
Last verified: December 2014